CT News and Research

RSS

Pfizer announces termination of HSR waiting period for acquisition of King

Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.

27 Jan 2011

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, although the overall diagnostic imaging market has been limited by reimbursement cuts and poor economic conditions, the next five years will see unit growth of approximately 5%.

27 Jan 2011

ACS NSQIP Pediatric helps hospitals prevent complications

A first of its kind surgical quality improvement program for children has the potential to identify outcomes of children's surgical care that can be targeted for quality improvement efforts to prevent complications and save lives. The results of a study of the American College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS NSQIP Peds) phase 1 pilot were published in the January issue of the Journal of the American College of Surgeons.

27 Jan 2011

New Mexico implements software module to link telemedicine services to other systems

New Mexico Software, a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the implementation of a software module that gives the company virtually unlimited ability to link its XR-EXpress telemedicine services to other systems.

27 Jan 2011

AG Mednet's image transfer service surpasses 2 million/month mark

AG Mednet, the world's largest medical image collection and delivery service announced today that the steady state volume of images transferred by its managed service has surpassed the 2 million/month mark. The company achieved impressive growth in utilization in 2010.

25 Jan 2011

ASU Biodesign Institute hosts international research consortium on early detection of lung cancer

To address the latest issues on the early detection of lung cancer, the Biodesign Institute at Arizona State University will host an international research consortium in Scottsdale, Ariz., Feb. 25-26.

25 Jan 2011

Also in Global Health News: Cholera death in DR; TB vaccine study; Rising food prices

"Dominican Republic on Sunday confirmed that a 53-year-old Haitian man has become the country's first death from cholera and announced the immediate start of a broad disease control and monitoring operation" around the eastern town of Higuey where he was being treated and later died, Latin American Herald Tribune reports (1/24).

24 Jan 2011

Hitachi Medical Systems America achieves top ranking among MRI vendors

In the 2010 Q4 User Satisfaction Survey, MD Buyline users have named Hitachi Medical Systems America (HMSA) the top rated MRI vendor. HMSA swept the top rankings in all six categories and earned a composite score 9.6 out of 10.

24 Jan 2011

CT scans can help physicians to diagnose abdominal pain, reduce health care costs

The use of CT scanning to evaluate abdominal pain in emergency departments can help physicians arrive at a diagnosis quickly and decisively. A study conducted at Massachusetts General Hospital and appearing in the February issue of the American Journal of Roentgenology also finds that information provided by CT scans changed treatment plans for almost half the patients studied and significantly reduced probable hospital admissions.

24 Jan 2011

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

FibroGen, today announced interim results of a phase 1/2 trial of FG-3019, a therapeutic antibody against connective tissue growth factor, in combination with gemcitabine and erlotinib in individuals with unresectable pancreatic cancer.

23 Jan 2011

Immunomedics reports encouraging results from Y-90-labeled clivatuzumab tetraxetan study in pancreatic cancer

Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that repeated therapy cycles of its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine, extended median overall survival.

21 Jan 2011

BOKA Powell releases new images of Methodist Hospital for Surgery in Texas

BOKA Powell released new images today of the completed Methodist Hospital for Surgery in Addison, Texas, a dedicated surgical hospital which opened last month.

21 Jan 2011

Viewpoints: Endorsing - and repudiating - health law repeal; Gov. Brewer on Ariz. Medicaid; Medical devices 'red tape'

The reason the GOP never got around to proposing a serious plan to expand coverage and control costs is because doing that is excruciatingly hard and politically dangerous. Look how long Democrats struggled to craft a measure and what happened to them after they passed it.

21 Jan 2011

No robust conclusions possible on advantages or disadvantages of PET

Malignant gliomas are fast-growing brain tumours with poor prospects of recovery depending on disease stage. Experts hope that the examination of patients by means of positron emission tomography (PET) is more helpful in the choice of the right treatment than other procedures. In a final report the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated the benefit of PET in the detection of recurrences. According to this report, no robust conclusions are possible on the advantages or disadvantages of PET.

20 Jan 2011

NQF implements quality measures pertaining to ambulatory emergency and urgent care

To improve healthcare quality and give patients and providers more information about the results of care, the National Quality Forum has endorsed 16 ambulatory care measures, with a particular focus on emergency and urgent care.

19 Jan 2011

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran's ig4 navigation system in the United States.

18 Jan 2011

Cardiac surgery market to reach over $4.4 billion by 2017

According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, percutaneous aortic valve replacement (PAVR) and percutaneous mitral valve repair (PMVR) devices are expected to enter the U.S. market in 2011 and grow to almost $1.3 billion by 2017.

18 Jan 2011

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.

18 Jan 2011

Stem cell exhibition to broaden debate on the issue

The topic remains complex and controversial, the technology innovative and promising, and the debate, on stem-cell research, continues unabated. And now, the subject is receiving the attention of a group not normally associated with scientific discoveries. University of Alberta printmaking professor, Sean Caulfield, along with U of A Health Law Institute research director and researcher, Tim Caulfield, have brought together a group of visual artists from Europe and North America to contribute to the stem-cell debate that often pits politicians, scientists, pundits and religious leaders against each other.

17 Jan 2011

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

BIOTRONIK SE Co. & KG highlights two key milestones toward receiving premarket approval (PMA) of the TactiCath, a novel technology for treating atrial fibrillation (AF): FDA IDE (investigational device exemption) approval and the first patient enrollment of the TOCCASTAR (TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation) clinical trial.

14 Jan 2011

CT News and Research

Pfizer announces termination of HSR waiting period for acquisition of King

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

ACS NSQIP Pediatric helps hospitals prevent complications

New Mexico implements software module to link telemedicine services to other systems

AG Mednet's image transfer service surpasses 2 million/month mark

ASU Biodesign Institute hosts international research consortium on early detection of lung cancer

Also in Global Health News: Cholera death in DR; TB vaccine study; Rising food prices

Hitachi Medical Systems America achieves top ranking among MRI vendors

CT scans can help physicians to diagnose abdominal pain, reduce health care costs

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Immunomedics reports encouraging results from Y-90-labeled clivatuzumab tetraxetan study in pancreatic cancer

BOKA Powell releases new images of Methodist Hospital for Surgery in Texas

Viewpoints: Endorsing - and repudiating - health law repeal; Gov. Brewer on Ariz. Medicaid; Medical devices 'red tape'

No robust conclusions possible on advantages or disadvantages of PET

NQF implements quality measures pertaining to ambulatory emergency and urgent care

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

Cardiac surgery market to reach over $4.4 billion by 2017

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

Stem cell exhibition to broaden debate on the issue

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News